ATG2B and neoplasm: Based on TIMER databases, a positive correlation was discovered between ATG2B and tumor-infiltrating lymphocytes, suggesting that ATG2B might influence the immunotherapy of CRC modulating the tumor-infiltrating immune cells, but functional studies of ATG2B still need further verification.